CD177 and breast cancer: Chemokine receptors on TI Treg cells were not significantly different between CD177+ and CD177− TI Treg cells from human breast cancer specimens (Fig. 6d), or between WT and Treg-KO TI-Treg cells from MC38 tumors (Fig. 6e).